合盛硅業(603260.SH):合盛新材擬增資擴股引進外部投資者等
格隆匯12月15日丨合盛硅業(603260.SH)公佈,為加快公司碳化硅業務的發展、擴大業務規模,確保滿足子公司正常運作所需資金需求,公司全資子公司合盛新材擬進行增資,註冊資本由1億元增加至1.25億元,新增註冊資本由外部投資者寧波聯江、厚一投資、孟擎實業以及公司關聯方暨公司副董事長羅燚,公司董事、總經理羅燁棟認繳。
公司董事、總經理羅燁棟共同對合盛新材投資2億元,新增註冊資本2500萬元,超過增加註冊資本的部分1.75億元計入合盛新材資本公積。

此次交易前,公司持有合盛新材 100.00%股權,此次交易完成後,公司持有
合盛新材 80.00%股權,合盛新材仍為公司合併報表範圍內控股子公司。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.